News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
700,820 Results
Type
Article (45452)
Company Profile (318)
Press Release (655050)
Section
Business (208472)
Career Advice (2200)
Deals (36209)
Drug Delivery (90)
Drug Development (82230)
Employer Resources (172)
FDA (16193)
Job Trends (15177)
News (351672)
Policy (33105)
Tag
Academia (2567)
Africa (795)
Alliances (50543)
Alzheimer's disease (1181)
Approvals (16116)
Arizona (181)
Artificial intelligence (91)
Asia (38863)
Australia (6501)
Bankruptcy (361)
Best Places to Work (11444)
Biotechnology (233)
Breast cancer (76)
C2C Services and Suppliers (79734)
California (2165)
Canada (1021)
Cancer (638)
Career advice (1822)
Cell therapy (163)
China (171)
Clinical research (64579)
Collaboration (208)
Colorado (88)
Compensation (112)
Connecticut (90)
COVID-19 (2548)
Cystic fibrosis (80)
Data (478)
Diabetes (99)
Diagnostics (6075)
Drug pricing (78)
Earnings (84566)
Employer resources (148)
Europe (84371)
Events (111825)
Executive appointments (191)
FDA (16498)
Florida (312)
Funding (195)
Gene therapy (112)
Georgia (68)
GLP-1 (554)
Government (4354)
Healthcare (18751)
Hotbed/Location (488701)
Illinois (297)
Indiana (158)
Infectious disease (2591)
Inflammatory bowel disease (100)
Interviews (349)
IPO (16526)
Job creations (3920)
Job search strategy (1579)
Kansas (98)
Layoffs (415)
Legal (8038)
Lung cancer (122)
Manufacturing (122)
Maryland (448)
Massachusetts (1787)
Medical device (13119)
Medtech (13124)
Mergers & acquisitions (19593)
Metabolic disorders (302)
Michigan (133)
Minnesota (237)
Neuroscience (1372)
New Jersey (669)
New York (672)
NextGen Class of 2024 (6640)
Non-profit (4503)
North Carolina (638)
Northern California (937)
Obesity (181)
Ohio (116)
Opinion (213)
Patents (83)
Pennsylvania (638)
People (57613)
Phase I (20111)
Phase II (28484)
Phase III (21161)
Pipeline (143)
Postmarket research (2572)
Preclinical (8526)
Press Release (72)
Radiopharmaceuticals (233)
Rare diseases (158)
Real estate (6239)
Regulatory (21750)
Research institute (2361)
Resumes & cover letters (373)
South America (1184)
Southern California (870)
Startups (3814)
Texas (283)
United States (9707)
Vaccines (518)
Washington State (272)
Weight loss (152)
Date
Today (71)
Last 7 days (661)
Last 30 days (2759)
Last 365 days (37413)
2024 (28127)
2023 (40705)
2022 (51899)
2021 (56370)
2020 (54693)
2019 (47156)
2018 (35600)
2017 (33141)
2016 (32595)
2015 (38465)
2014 (33845)
2013 (28964)
2012 (29450)
2011 (30119)
2010 (28199)
700,820 Results for "packgene biotech inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
PackGene Biotech and Kudo Biotechnology Partner to Offer Customized mRNA Manufacturing Services
PackGene Biotech (PackGene) and Kudo Biotechnology (Kudo Bio) have partnered to provide high-quality, customized messenger RNA (mRNA) manufacturing services for drug and vaccine development.
September 19, 2023
·
5 min read
Lone Star Bio
PackGene Biotech Inc. Breaks Ground on cGMP Biomanufacturing and Process Development Facility in Houston
PackGene Biotech Inc. announced the expansion of its U.S. services with a new cGMP biomanufacturing and processing facility in Houston.
February 23, 2023
·
4 min read
Business
Kane Biotech Signs Worldwide License Agreement with Montreal-Based I-MED Pharma Inc.First Commercial Agreement for DispersinB®
Kane Biotech Inc. announces that it has entered into a worldwide license agreement with I-MED Pharma Inc. (“I-MED Pharma” or “I-MED”) for the DispersinB ® technology.
June 25, 2024
·
3 min read
Press Releases
Mercury Bio Appoints Biotech Innovator Alex Koglin, Ph.D. to Board of Directors
With the addition of NTx’s co-founder and former President to the board Mercury Bio significantly enhances its strategic reach in the biotech sector
October 1, 2024
·
2 min read
Press Releases
Alopexx Announces Investment from Biotech Consortia, Inc.
September 6, 2024
·
4 min read
Sponsored
SignalChem Biotech, World Leader in Kinases, Is Now Part of Sino Biological
Sino Biological, Inc. has successfully concluded the acquisition of Vancouver-based Canadian biotechnology company SignalChem Biotech Inc.
July 15, 2024
·
3 min read
Deals
After Fed Rate Cut, Biotech Stocks Face ‘Anticlimactic’ Reality
The drop in interest rate is slightly bigger than anticipated and good news for the biotech industry, but little will change in the near term.
September 19, 2024
·
3 min read
·
Annalee Armstrong
Kane Biotech Makes First Commercial Sale of revyve™ Antimicrobial Wound Gel to Progena
Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has made its first commercial-scale sale of revyve™ Antimicrobial Wound Gel product (“revyve™”) to ProgenaCare Global LLC (“ProgenaCare”).
June 27, 2024
·
4 min read
Press Releases
Pharmagreen Biotech, Inc. (PHBI) Reaffirms Commitment to Non-Toxic Financing Amid Ongoing Business Development Progress
September 19, 2024
·
4 min read
Business
Kane Biotech Announces First Quarter 2024 Financial Results
Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces its first quarter 2024 financial results.
May 23, 2024
·
8 min read
1 of 70,082
Next
